The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,810.00
Bid: 1,811.00
Ask: 1,811.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 1,805.00
High: 1,812.50
Low: 1,797.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Morgan Stanley upgrades Centrica to Overweight

Thu, 07th Oct 2021 09:40

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

CITIGROUP RAISES LEGAL & GENERAL PRICE TARGET TO 336 (301) PENCE - 'BUY'

----------

MORGAN STANLEY CUTS GLAXOSMITHKLINE PRICE TARGET TO 1,555 PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY CUTS SCHRODERS TARGET TO 3,700 (3,890) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY CUTS HARGREAVES LANDSDOWN TARGET TO 1,381 PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY CUTS ABRDN PRICE TARGET TO 289 (305) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES PRUDENTIAL PRICE TARGET TO 1,764 (1,706) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES RENTOKIL INITIAL TARGET TO 645 (620) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES EXPERIAN PRICE TARGET TO 3,500 (3,320) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES ANGLO AMERICAN PRICE TARGET TO 4,100 (3,900) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS ANGLO AMERICAN PRICE TARGET TO 3,700 (4,300) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS RIO TINTO PRICE TARGET TO 5,400 (6,910) PENCE - 'NEUTRAL'

----------

BERENBERG CUTS RIO TINTO PRICE TARGET TO 5,400 (6,900) PENCE - 'HOLD'

----------

GOLDMAN SACHS RAISES ANTOFAGASTA PRICE TARGET TO 1,750 (1,700) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES GLENCORE PRICE TARGET TO 470 (430) PENCE - 'BUY'

----------

BERENBERG CUTS BHP GROUP PRICE TARGET TO 2,200 (2,300) PENCE - 'HOLD'

----------

JEFFERIES CUTS POLYMETAL PRICE TARGET TO 1,725 (1,900) PENCE - 'BUY'

----------

BERENBERG CUTS POLYMETAL PRICE TARGET TO 2,200 (2,300) PENCE - 'BUY'

----------

JEFFERIES CUTS FRESNILLO PRICE TARGET TO 1,280 (1,300) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES RELX PRICE TARGET TO 2,500 (2,430) PENCE - 'OUTPERFORM'

----------

UBS RAISES RELX PRICE TARGET TO 2,135 (2,040) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES TESCO PRICE TARGET TO 330 (300) PENCE - 'OVERWEIGHT'

----------

GOLDMAN SACHS RAISES TESCO PRICE TARGET TO 320 (310) PENCE - 'BUY'

----------

BARCLAYS RAISES TESCO PRICE TARGET TO 325 (310) PENCE - 'OVERWEIGHT'

----------

BERNSTEIN RAISES TESCO PRICE TARGET TO 330 (280) PENCE - 'OUTPERFORM'

----------

RBC CUTS BURBERRY PRICE TARGET TO 1,950 (2,160) PENCE - 'SECTOR PERFORM'

----------

FTSE 250

----------

MORGAN STANLEY RAISES CENTRICA TO 'OVERWEIGHT' (EQUAL WEIGHT) - TARGET 75 (58) PENCE

----------

MORGAN STANLEY CUTS MAN GROUP PRICE TARGET TO 253 (255) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY CUTS ASHMORE GROUP TARGET TO 376 (412) PENCE - 'EQUAL-WEIGHT'

----------

JPMORGAN CUTS ASHMORE GROUP PRICE TARGET TO 340 (360) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY CUTS HOMESERVE TARGET TO 1,020 (1,110) PENCE - 'EQUAL-WEIGHT'

----------

DEUTSCHE BANK INITIATES MARSHALLS WITH 'BUY' - TARGET 885 PENCE

----------

BERENBERG RAISES HOCHSCHILD MINING TO 'BUY' ('HOLD') - TARGET 200 PENCE

----------

BERENBERG CUTS CENTAMIN PRICE TARGET TO 137 (138) PENCE - 'BUY'

----------

JEFFERIES CUTS CENTAMIN PRICE TARGET TO 170 (175) PENCE - 'BUY'

----------

RBC RAISES PAGEGROUP PRICE TARGET TO 760 (700) PENCE - 'OUTPERFORM'

----------

RBC CUTS TRITAX BIG BOX PRICE TARGET TO 260 (265) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES BRITVIC PRICE TARGET TO 1050 (900) PENCE - 'BUY'

----------

JEFFERIES RAISES TRAVIS PERKINS PRICE TARGET TO 2,220 (2,168) PENCE - 'BUY'

----------

JEFFERIES RAISES OXFORD INSTRUMENTS PRICE TARGET TO 2,445 (2,415) PENCE - 'HOLD'

----------

DZ BANK CUTS FAIR VALUE FOR TUI TO 2.00 (2.60) EUR - 'SELL'

----------

MORGAN STANLEY CUTS TUI PRICE TARGET TO 140 (160) PENCE - 'UNDERWEIGHT'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG RAISES GEM DIAMONDS TO 'BUY' ('HOLD') - TARGET 80 (70) PENCE

----------

BERENBERG RAISES IMPAX GROUP PRICE TARGET TO 1,400 (1,360) PENCE - 'BUY'

----------

BERENBERG RAISES PENDRAGON PRICE TARGET TO 28 (27) PENCE - 'BUY'

----------

RBC RAISES CVS GROUP PRICE TARGET TO 3,100 (2,750) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES KENMARE RESOURCES PRICE TARGET TO 580 (530) PENCE - 'BUY'

----------

BERENBERG CUTS GRIFFIN PRICE TARGET TO 175 (200) PENCE - 'BUY'

----------

BERENBERG CUTS GREATLAND GOLD PRICE TARGET TO 26 (29) PENCE - 'BUY'

----------

BERENBERG RAISES CENTRAL ASIA METALS PRICE TARGET TO 320 (300) PENCE - 'BUY'

----------

BERENBERG RAISES NICHOLS PRICE TARGET TO 1,350 (1,200) PENCE - 'HOLD'

----------

BERENBERG RAISES FEVERTREE DRINKS PRICE TARGET TO 2,700 (2,500) PENCE - 'BUY'

----------

BERENBERG RAISES AG BARR PRICE TARGET TO 570 (450) PENCE - 'HOLD'

----------

GOLDMAN SACHS RAISES SUPERMARKET INCOME REIT PRICE TARGET TO 136 (134) PENCE - 'BUY'

----------

JPMORGAN RAISES PETROFAC PRICE TARGET TO 170 (120) PENCE - 'NEUTRAL'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more
20 Feb 2024 08:55

IN BRIEF: Diageo welcomes GSK's CFO as non-executive director

Diageo PLC - London-based brewer and distiller sells more than 200 drinks brands, including Guinness stout, Captain Morgan rum and Johnnie Walker whisky - Appoints GSK PLC's chief financial officer and executive director, Julie Brown, as a non-executive director. Says she will succeed Alan Stewart as chair of the audit committee after his retirement following the firm's annual general meeting in September. Chair Javier Ferran says: "Julie brings many years of experience in financial, commercial and strategic roles in international companies operating in highly regulated industries. She is strongly committed to enabling diversity in business and to creating sustainable, long-term value for stakeholders. I look forward to her contribution to Board discussions and to working with her in progressing Diageo's ambition to be one of the most trusted and respected consumer products companies in the world."

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
15 Feb 2024 11:02

Berenberg hikes target price on GSK

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker GSK from £16.50 to £18.20 on Thursday, stating the group was moving closer to offsetting losses associated with the expiry of its patent on HIV drug dolutegravir.

Read more
15 Feb 2024 09:45

LONDON BROKER RATINGS: Jefferies cuts Kingfisher but Citi raises

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
15 Feb 2024 08:49

GSK completes USD1.4 billion purchase of respiratory firm Aiolos Bio

(Alliance News) - GSK PLC on Thursday said it has completed the acquisition of Aiolos Bio Ltd, expanding its respiratory portfolio with a potential "best-in-class" asthma treatment.

Read more
13 Feb 2024 16:53

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.